CFTR and cystic fibrosis: Notably, our study has shown that the CF airway inflammatory milieu from advanced CF lung disease (SMM) improves the efficacy of various therapeutic combinations of CFTR modulators regarding their ability to increase F508del CFTR responses (Figures 1, 2, 4).